Is Pharnext SCA halal to invest in?

According to Musaffa's Shariah screening methodology, Pharnext SCA (ALPHA.PA) is currently classified as NOT HALAL as of September 2024. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Pharnext SCA a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Pharnext SCA using these criteria to determine its compliance status.

Can Muslims buy shares of Pharnext SCA?

Muslim investors may consider investing in Pharnext SCA if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Pharnext SCA classified as NOT HALAL?

Musaffa determines the Shariah status of Pharnext SCA by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Pharnext SCA updated?

The Shariah compliance status of Pharnext SCA may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Pharnext SCA become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Pharnext SCA?

You can check the latest Shariah compliance status of Pharnext SCA on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Pharnext SCA ALPHA.PA

€0.00

Last Updated: Aug 26, 12:00 AM·XPAR

ALPHA.PA Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: September 14, 2024

Report Source: 2023 Annual Report

Analyst's Ratings for Pharnext SCA (ALPHA.PA)

Based on 9 analysts giving stock ratings to Pharnext SCA in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Pharnext SCA. Stock Analysis ALPHA.PA

France Health Care Nano Cap Report: 2023 Annual

Pharnext is an advanced clinical-stage biopharmaceutical company founded in April 2007 by renowned scientists and entrepreneurs including Professor Daniel Cohen and collaborators, pioneers in modern genomics. The company is headquartered in Suresnes, Ile-De-France. The firm is focused on discovering, developing and licensing new therapeutic solutions (Pleodrugs) and companion tests for unmet medical needs (large and niche markets) by using the Pleotherapy approach. Pharnext SA runs all its own activities, from research through to clinical development (no further than the end of Phase II trials), and then licenses the Pleodrugs to industrial partners. The firm's prime focus is on neurodegenerative diseases and metabolic diseases.

Key Statistics of Pharnext SCA (ALPHA.PA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€0.00€0.00

Today's Open

€0.00

Volume

3.74M

P/E Ratio (TTM)

52 Week Range

€0.00€23,500,000.00

Market Cap

1172.00

Avg. Volume

11.87M

Dividend Yield

Financial Metrics & Statements of Pharnext SCA (ALPHA.PA)

FAQ's for Pharnext SCA (ALPHA.PA)

According to Musaffa’s Shariah screening methodology, Pharnext SCA (ALPHA.PA) is currently classified as NOT HALAL as of September 2024. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.